Metformin-Associated Lactic Acidosis: Predisposing Factors and Outcome

被引:28
作者
Kim, Min Ju [1 ]
Han, Ju Young [1 ]
Shin, Jun Young [1 ]
Kim, Shin Il [1 ]
Lee, Jeong Min [1 ]
Hong, Seongbin [1 ]
Kim, So Hun [1 ]
Nam, Moon Suk [1 ]
Kim, Yong Seong [1 ]
机构
[1] Inha Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, 27 Inhang Ro, Incheon 400711, South Korea
关键词
Metformin; Acidosis; lactic; Diabetes mellitus; type; 2;
D O I
10.3803/EnM.2015.30.1.78
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Metformin is considered the first choice oral treatment for type 2 diabetes patients in the absence of contraindications. Rarely, life-threatening complications associated with metformin treatment are seen in some patients with underlying diseases. The aim of this study was to further investigate the clinical profiles and risk factors for metformin-associated lactic acidosis (MALA) and the treatment modalities according to survival. Methods: To identify MALA, we performed a retrospective study in seven diabetic patients who were taking metformin and had been diagnosed with lactic acidosis at Inha University Hospital between 1995 and 2012. For each patient, we recorded the age, sex, daily metformin dosage, laboratory test results, admission diagnosis, and risk factors. Also, concurrent conditions, treatment modalities, and outcomes were evaluated. Results: Six patients had risk factors for lactic acidosis before admission. All patients had renal impairment on admission as a precipitating risk factor. Five patients survived and two patients died despite early renal replacement therapy. Older patients tended to have a poorer prognosis. Conclusion: Renal function must be monitored in elderly type 2 diabetes mellitus patients with underlying diseases and conditions causing renal impairment who begin metformin treatment. Accurate recognition of MALA and initiation of renal replacement are essential for treatment.
引用
收藏
页码:78 / 83
页数:6
相关论文
共 17 条
  • [1] Metformin and lactic acidosis
    Ashall, V.
    Dawes, T.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2008, 101 (06) : 876 - 877
  • [2] Drug therapy - Metformin
    Bailey, CJ
    Turner, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) : 574 - 579
  • [3] Comparative outcomes study of metformin intervention versus conventional approach - The COSMIC approach study
    Cryer, DR
    Nicholas, SP
    Henry, DH
    Mills, DJ
    Stadel, BV
    [J]. DIABETES CARE, 2005, 28 (03) : 539 - 543
  • [4] Metformin-associated lactic acidosis following acute kidney injury. Efficacious treatment with continuous renal replacement therapy
    Dichtwald, S.
    Weinbroum, A. A.
    Sorkine, P.
    Ekstein, M. P.
    Dahan, E.
    [J]. DIABETIC MEDICINE, 2012, 29 (02) : 245 - 250
  • [5] Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function
    Duong, Janna K.
    Kumar, Shaun S.
    Kirkpatrick, Carl M.
    Greenup, Louise C.
    Arora, Manit
    Lee, Toong C.
    Timmins, Peter
    Graham, Garry G.
    Furlong, Timothy J.
    Greenfield, Jerry R.
    Williams, Kenneth M.
    Day, Richard O.
    [J]. CLINICAL PHARMACOKINETICS, 2013, 52 (05) : 373 - 384
  • [6] Contraindications to metformin therapy in patients with Type 2 diabetes - a population-based study of adherence to prescribing guidelines
    Emslie-Smith, AM
    Boyle, DIR
    Evans, JMM
    Sullivan, F
    Morris, AD
    [J]. DIABETIC MEDICINE, 2001, 18 (06) : 483 - 488
  • [7] BIGUANIDE-ASSOCIATED LACTIC-ACIDOSIS - CASE-REPORT AND REVIEW OF THE LITERATURE
    GAN, SC
    BARR, J
    ARIEFF, AI
    PEARL, RG
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (11) : 2333 - 2336
  • [8] Kang Byoung Il, 2011, [The Korean Journal of Medicine, 대한내과학회지], V80, P473
  • [9] 최혜숙, 2004, Kidney Research and Clinical Practice, V23, P143
  • [10] Salpeter SR, 2010, COCHRANE DATABASE SY